ALPROLIX subst sèche 250 UI cum solv flac

7680660390012 CH-66039 B02BD04 06.01.1.

Reimbursement limitations:

ALPROLIX2

Prophylaxie et thérapie d'hémorragies chez les patients traités précédemment et atteints d'hémophilie B (déficit congénital …

ALPROLIX subst sèche 250 UI cum solv flac
ALPROLIX subst sèche 250 UI cum solv flac
ALPROLIX subst sèche 250 UI cum solv flac
1 / 3
google

Details

Product number
6603901
CPT
-
Packaging group
-
Unit
(1 Durchstechflasche mit Pulver und 1 Fertigspritze mit Lösungsmittel) und Verabreichungsset
Composition
Praeparatio cryodesiccata: eftrenonacogum alfa 250 U.I., histidinum, mannitolum, saccharum, polysorbatum 20, acidum hydrochloridum aut natrii hydroxidum ad pH, pro vitro. Solvens: natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp. natrium 6.4 mg.

Articles (1)

Alprolix 250 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
15/06/2022
Professional SmPC
Français
15/06/2022
Professional SmPC
Italien
15/06/2022

Detailed composition

Substance Quantity Type Category
PRC
250.0 UI Substance Wirkstoff (Principe actif)
SOLV
- Substance HNIDK
SOLV
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
SOLV
6.4 MG Substance HBESI
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK

Reimbursement information

Public price
CHF 366.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2017

Authorization holder

Swedish Orphan Biovitrum AG

4058 Basel

Authorization information

Swissmedic authorization number
66039
Drug name
Alprolix, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Galenic form
PULMJ
ATC Code
B02BD04
Authorization status
Z
Dispensation category
B
First authorization
25/10/2016
Authorization expiration date
31/12/9999
IT number
06.01.1.
Domain
Human medicine
Field of application
Behandlung und Prophylaxe von Blutungen bei Patienten mit Hämophilie B (kongenitaler Faktor IX-Mangel).

Packaging details

Description (FR)
ALPROLIX subst sèche 250 UI cum solv flac
Description (DE)
ALPROLIX Trockensub 250 IE cum Solv Durchstf
Market launch
25/10/2016
Narcotic (BTM)
No

Other packaging sizes

ALPROLIX subst sèche 500 UI cum solv flac
None LEER
GTIN: 7680660390029
View
ALPROLIX subst sèche 1000 UI cum solv flac
None LEER
GTIN: 7680660390036
View
ALPROLIX subst sèche 2000 UI cum solv flac
None LEER
GTIN: 7680660390043
View
ALPROLIX subst sèche 3000 UI c solv flac
None LEER
GTIN: 7680660390067
View